Related references
Note: Only part of the references are listed.The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
Pierrick G. J. Fournier et al.
CANCER CELL (2015)
Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
Sidi Chen et al.
CELL (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?
Joyce M. van Dodewaard-de Jong et al.
CLINICAL GENITOURINARY CANCER (2015)
Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant
Wies van Roosmalen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem et al.
NATURE (2015)
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
Matthew K. H. Hong et al.
NATURE COMMUNICATIONS (2015)
Mouse models of prostate cancer: picking the best model for the question
Magdalena M. Grabowska et al.
CANCER AND METASTASIS REVIEWS (2014)
Role of Sorafenib in Overcoming Resistance of Chemotherapy-Failure Castration-Resistant Prostate Cancer
Andrew Meyer et al.
CLINICAL GENITOURINARY CANCER (2014)
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12
Arnaud Duquet et al.
EMBO MOLECULAR MEDICINE (2014)
Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity
Khanh-Quynh N. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Clinical Targeting of Mutated and Wild-Type Protein Tyrosine Kinases in Cancer
Justin M. Drake et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
The clinical development of MEK inhibitors
Yujie Zhao et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis
Kerstin W. Sinkevicius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration
Juliane Mooz et al.
SCIENCE SIGNALING (2014)
MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
Kristina H. Knubel et al.
ONCOTARGET (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
FGFR1 Is Essential for Prostate Cancer Progression and Metastasis
Feng Yang et al.
CANCER RESEARCH (2013)
Effects of Androgen Deprivation Therapy and Bisphosphonate Treatment on Bone in Patients With Metastatic Castration-Resistant Prostate Cancer: Results From the University of Washington Rapid Autopsy Series
Colm Morrissey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
MERTK receptor tyrosine kinase is a therapeutic target in melanoma
Jennifer Schlegel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
M. Katie Conley-LaComb et al.
MOLECULAR CANCER (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme
Y. Wang et al.
ONCOGENE (2013)
Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets
Justin M. Drake et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
Alvaro Aytes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
David J. Mulholland et al.
CANCER RESEARCH (2012)
Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases
Zhihu Ding et al.
CELL (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression
Justin M. Drake et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Proinvasion Metastasis Drivers in Early-Stage Melanoma Are Oncogenes
Kenneth L. Scott et al.
CANCER CELL (2011)
Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy
Houjian Cai et al.
CANCER RESEARCH (2011)
Steps in prostate cancer progression that lead to bone metastasis
Jung-Kang Jin et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes et al.
MOLECULAR CANCER THERAPEUTICS (2011)
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding et al.
NATURE (2011)
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
Akash Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Compensatory Upregulation of Tyrosine Kinase Etk/BMX in Response to Androgen Deprivation Promotes Castration-Resistant Growth of Prostate Cancer Cells
Bojie Dai et al.
CANCER RESEARCH (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain
Joseph R. Ghilardi et al.
MOLECULAR PAIN (2010)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Nallasivam Palanisamy et al.
NATURE MEDICINE (2010)
Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells
Y. Gan et al.
ONCOGENE (2010)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Targeting src family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model
Serk In Park et al.
CANCER RESEARCH (2008)
A phase II clinical trial of sorafenib in androgen-independent prostate cancer
William L. Dahut et al.
CLINICAL CANCER RESEARCH (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition
Victor D. Acevedo et al.
CANCER CELL (2007)
Prostate cancer specific integrin αvβ3 modulates bone metastatic growth and tissue remodeling
N. P. McCabe et al.
ONCOGENE (2007)
Raf kinases: Function, regulation and role in human cancer
Deborah T. Leicht et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development
Jing Jiao et al.
CANCER RESEARCH (2007)
Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis
Thomas R. Geiger et al.
CANCER RESEARCH (2007)
Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation
Nupam P. Mahajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Regulation of androgen receptor activity by tyrosine phosphorylation
Zhiyong Guo et al.
CANCER CELL (2006)
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
S Douma et al.
NATURE (2004)
Hepsin promotes prostate cancer progression and metastasis
O Klezovitch et al.
CANCER CELL (2004)
In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme
L Xin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mechanisms of disease: Prostate cancer
WG Nelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Molecular imaging of cancer with positron emission tomography
SS Gambhir
NATURE REVIEWS CANCER (2002)
Raf induces TGFβ production while blocking its apoptotic but not invasive responses:: a mechanism leading to increased malignancy in epithelial cells
K Lehmann et al.
GENES & DEVELOPMENT (2000)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)